PT2970345T - Agentes de formação de imagem por tep sobre o amep marcado no 18f - Google Patents

Agentes de formação de imagem por tep sobre o amep marcado no 18f

Info

Publication number
PT2970345T
PT2970345T PT14721640T PT14721640T PT2970345T PT 2970345 T PT2970345 T PT 2970345T PT 14721640 T PT14721640 T PT 14721640T PT 14721640 T PT14721640 T PT 14721640T PT 2970345 T PT2970345 T PT 2970345T
Authority
PT
Portugal
Prior art keywords
imaging agents
pet imaging
labeled psma
targeted pet
targeted
Prior art date
Application number
PT14721640T
Other languages
English (en)
Inventor
Berkman Clifford
A Stekhova Svetlana
Original Assignee
Cancer Targeted Tech Llc
Univ Washington State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Targeted Tech Llc, Univ Washington State filed Critical Cancer Targeted Tech Llc
Publication of PT2970345T publication Critical patent/PT2970345T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0489Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0402Organic compounds carboxylic acid carriers, fatty acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2404Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2404Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2416Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic of cycloaliphatic alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2454Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2458Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT14721640T 2013-03-15 2014-03-14 Agentes de formação de imagem por tep sobre o amep marcado no 18f PT2970345T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361798108P 2013-03-15 2013-03-15

Publications (1)

Publication Number Publication Date
PT2970345T true PT2970345T (pt) 2019-09-06

Family

ID=50639969

Family Applications (2)

Application Number Title Priority Date Filing Date
PT14721640T PT2970345T (pt) 2013-03-15 2014-03-14 Agentes de formação de imagem por tep sobre o amep marcado no 18f
PT191797588T PT3560937T (pt) 2013-03-15 2014-03-14 Métodos de preparação de agentes de imagem por tep direcionados para amep marcado no 18f'' e seus métodos de diagnóstico

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT191797588T PT3560937T (pt) 2013-03-15 2014-03-14 Métodos de preparação de agentes de imagem por tep direcionados para amep marcado no 18f'' e seus métodos de diagnóstico

Country Status (16)

Country Link
US (2) US11554183B2 (pt)
EP (3) EP3560937B1 (pt)
CN (2) CN108558939B (pt)
AU (2) AU2014228233B2 (pt)
CA (1) CA2903131C (pt)
DK (2) DK2970345T3 (pt)
ES (2) ES2743433T3 (pt)
FI (1) FI3560937T3 (pt)
HR (2) HRP20230109T1 (pt)
HU (2) HUE061402T2 (pt)
LT (2) LT3560937T (pt)
PL (2) PL2970345T3 (pt)
PT (2) PT2970345T (pt)
RS (1) RS64011B1 (pt)
SI (2) SI3560937T1 (pt)
WO (1) WO2014143736A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11078166B2 (en) 2015-08-13 2021-08-03 The Johns Hopkins University Triazole conjugated ureas, thioureas, carbamates, and reversed carbamates for PSMA-targeted imaging agents and uses thereof
BR112019002560B1 (pt) * 2016-08-10 2022-08-16 Cancer Targeted Technology Llc Composto, composição farmacêutica, seus usos e método de preparação do mesmo
EP3600024A4 (en) 2017-03-22 2021-01-06 SafeOp Surgical, Inc. MEDICAL SYSTEMS AND METHODS FOR DETECTION OF CHANGES IN ELECTROPHYSIOLOGICALLY AVOID POTENTIALS
WO2018233798A1 (en) 2017-06-20 2018-12-27 ITM Isotopen Technologien München AG NOVEL PSMA BINDING AGENTS AND USE THEREOF
CA3060143A1 (en) 2017-05-24 2018-11-29 Itm Isotopen Technologien Munchen Ag Novel psma-binding agents and uses thereof
WO2020108753A1 (en) 2018-11-28 2020-06-04 ITM Isotopen Technologien München AG Novel tumor antigen binding agents and uses thereof
WO2020224780A1 (en) 2019-05-08 2020-11-12 ITM Isotopen Technologien München AG Para-aminohippuric acid (pah) as a renal protective substance
WO2021046233A1 (en) 2019-09-03 2021-03-11 Cancer Targeted Technology Llc Chelate-containing psma inhibitors
WO2022096103A1 (en) 2020-11-05 2022-05-12 ITM Isotopen Technologien München AG Combination of para-aminohippuric acid (pah) and radiolabeled complexes for treating cancer
WO2022111800A1 (en) 2020-11-25 2022-06-02 Itm Solucin Gmbh Stable formulations for radionuclide complexes
JP2024514293A (ja) 2021-04-02 2024-04-01 ノバルティス アーゲー 前立腺がんの診断方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2397973T3 (es) 2006-03-14 2013-03-12 Cancer Targeted Technology Llc Inhibidores peptidomiméticos del PSMA, compuestos que los comprenden y métodos de utilización
CA2858907A1 (en) * 2006-09-08 2008-03-13 Bayer Schering Pharma Aktiengesellschaft Compounds and methods for 18f labeled agents
CN102171187B (zh) * 2008-08-01 2017-07-28 约翰.霍普金斯大学 Psma‑结合剂及其用途
US9328129B2 (en) * 2010-11-12 2016-05-03 Washington State University Peptidomimetic inhibitors of PSMA
CA2839195C (en) * 2011-06-15 2021-10-26 Cancer Targeted Technology Llc Chelated psma inhibitors
CN102757296B (zh) * 2012-04-10 2014-11-19 中国科学院上海应用物理研究所 一种对化合物进行[18f]标记的方法
WO2013173630A1 (en) * 2012-05-16 2013-11-21 Cancer Targeted Technology, Llc Formulation of radiopharmaceuticals containing multiple acidic groups
WO2013173583A1 (en) * 2012-05-16 2013-11-21 Cancer Targeted Technology, Llc Psma inhibitors

Also Published As

Publication number Publication date
EP4180438A1 (en) 2023-05-17
AU2019203610A1 (en) 2019-06-13
AU2014228233B2 (en) 2019-02-28
HUE046194T2 (hu) 2020-02-28
CN105308056B (zh) 2018-03-20
US11554183B2 (en) 2023-01-17
CA2903131C (en) 2021-11-23
PT3560937T (pt) 2023-02-13
HRP20230109T1 (hr) 2023-04-28
HRP20191482T1 (hr) 2019-11-15
US20160030605A1 (en) 2016-02-04
ES2937955T3 (es) 2023-04-03
RS64011B1 (sr) 2023-03-31
AU2019203610B2 (en) 2021-02-04
EP3560937A1 (en) 2019-10-30
CN108558939B (zh) 2021-08-24
DK3560937T3 (da) 2023-02-13
HUE061402T2 (hu) 2023-06-28
SI3560937T1 (sl) 2023-04-28
CN108558939A (zh) 2018-09-21
WO2014143736A1 (en) 2014-09-18
EP2970345A1 (en) 2016-01-20
EP2970345B1 (en) 2019-06-19
CN105308056A (zh) 2016-02-03
AU2014228233A1 (en) 2015-09-17
CA2903131A1 (en) 2014-09-18
SI2970345T1 (sl) 2019-11-29
DK2970345T3 (da) 2019-08-26
LT3560937T (lt) 2023-03-27
LT2970345T (lt) 2019-09-25
US20230144322A1 (en) 2023-05-11
PL3560937T3 (pl) 2023-03-27
EP3560937B1 (en) 2022-12-28
ES2743433T3 (es) 2020-02-19
FI3560937T3 (fi) 2023-02-28
PL2970345T3 (pl) 2019-12-31

Similar Documents

Publication Publication Date Title
EP2951642A4 (en) OMNISTEREO IMAGING
GB201304149D0 (en) Ultrasound imaging
EP2948047A4 (en) IMAGING BODY STRUCTURES
EP2996149A4 (en) SEMICONDUCTOR IMAGING DEVICE
GB201315248D0 (en) Imaging
HUE046194T2 (hu) 18F-jelölt PSMA-célzott PET képalkotó ágensek
EP2866445A4 (en) IMAGING DEVICE
EP2964658A4 (en) SUBSTITUTED ORGANOFLUOROBORATES AS IMAGING AGENTS
HK1213459A1 (zh) 醫療成像
EP3007435A4 (en) SOLID STATE IMAGING DEVICE
EP2868258A4 (en) IMAGING SYSTEM
EP3041222A4 (en) IMAGING DEVICE
PL3011321T3 (pl) Obrazowanie rentgenowskie z kodowaną przesłoną
EP2944266A4 (en) ULTRASOUND IMAGING DEVICE
PL3038468T3 (pl) Środek bakteriobójczy
EP3087920A4 (en) IMAGING DEVICE FOR ANIMALS
EP2950517A4 (en) IMAGING DEVICE
GB201319610D0 (en) Image processor
EP2980561A4 (en) IMAGING SYSTEM
GB2530691B (en) Radiation imaging
SG11201601628VA (en) Photoacoustic imaging contrast agent composition
EP2975836A4 (en) IMAGING DEVICE
GB201322068D0 (en) Barrier components for animal stalls
GB201302036D0 (en) Diagnosis
GB201402877D0 (en) Bait Fixing device